Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Gynecol Oncol. 2023 Feb 16;171:15–22. doi: 10.1016/j.ygyno.2023.01.037

Figure 2: Kaplan-Meyer estimate of overall survival for patients with endometrial carcinoma according to CD8+ infiltration defined by ssGSEA and CIBERSORT.

Figure 2:

Endometrial cancers from TCGA of all molecular subtypes (n=232) were classified into CD8+ high (blue solid line) or CD8+ low (orange dashed line) defined by their distribution around the median CD8+ infiltration for the entire cohort using ssGSEA (A) or CIBERSORT (B). Kaplan-Meyer estimates are shown.